Home > Insider Trading > Verastem Inc. > Profile

Verastem Inc. (VSTM)

Sector: Pharmaceutical Preparations

Related Insiders

M Brian Stuglik, Chief Executive Officer, 2019-07-31
Dan Paterson, President And Coo, 2019-06-26
Gina Consylman, Director, 2019-06-26

M Brian Stuglik, Chief Executive Officer, 2019-07-31
Dan Paterson, President And Coo, 2019-06-26
Gina Consylman, Director, 2019-06-26
E. Robert Gagnon, Chief Financial Officer, 2019-06-26
Bruce Wendel, Director, 2019-06-26
Frances Alison Lawton, Director, 2019-06-26
Michael Kauffman, Director, 2019-06-26
K Eric Rowinsky, Director, 2019-06-26
J Timothy Barberich, Director, 2019-06-26
Louise S. Phanstiel, Other, 2019-02-13
Robert Forrester, President And Ceo, 2019-02-13
H. Steven Bloom, Chief Strategy Officer, 2019-01-07
M Joseph Lobacki, Executive Vp & Cco, 2019-01-07
Le Ngocdiep T. Md, Phd, Chief Medical Officer, 2018-10-02
B Julie Feder, Chief Financial Officer, 2018-06-04
Gregory Berk, Chief Medical Officer, 2017-01-11
Joseph Chiapponi, Vice President Of Finance, 2017-01-11
A Paul Friedman, Director, 2016-06-16
B John Green, Chief Financial Officer, 2016-01-04
H Christoph Westphal, Executive Chairman, 2015-07-01
Monica Singh, General Counsel, 2015-06-30
A Henri Termeer, Director, 2015-06-16
A Stephen Sherwin, Director, 2015-06-16
Joanna Horobin, Chief Medical Officer, 2015-01-12
Jonathan Pachter, Vp, Head Of Research, 2014-08-05
Richard Aldrich, Director, 2014-06-11
Longwood Fund, L.p., Large Shareholder, 2014-01-27
Chp Iii Lp, Large Shareholder, 2013-06-13
K John Clarke, Director, 2013-06-13
Deer Management Co. Llc, Large Shareholder, Director, 2012-03-08
Stephen Kraus, Director, 2012-03-08
Ansbert Gadicke, Director, 2012-03-08
Luke Evnin, Other, 2012-02-03
M Vaughn Kailian, Other, 2012-02-03
Steven Peter St, Other, 2012-02-03
Paul James Scopa, Other, 2012-02-03
John Vort Vander, Other, 2012-02-03
Todd Foley, Other, 2012-02-03
Mpm Bioventures V Gp Llc, Other, 2012-02-03
Mpm Bioventures V Llc, Other, 2012-02-03
Mpm Bioventures V, L.p., Other, 2012-02-03
Mpm Asset Management Investors Bv5 Llc, Other, 2012-02-03
L.p. Institutional Vii Partners Venture Bessemer, Large Shareholder, Director, 2012-02-03
Bvp Vii Special Opportunity Fund Lp, Large Shareholder, Director, 2012-02-03
L.p. Vii Partners Venture Bessemer, Large Shareholder, Director, 2012-02-03
Deer Vii & Co. Ltd., Large Shareholder, Director, 2012-02-03
Deer Vii & Co. L.p., Large Shareholder, Director, 2012-02-03
Piyush Gupta, Large Shareholder, 2012-02-03
Chp Iii Management, L.l.c., Large Shareholder, 2012-01-31
A Robert Weinberg, Large Shareholder, 2012-01-27
S Eric Lander, Large Shareholder, 2012-01-27

Show All Insiders (51)

Hedge Fund Holdings

Filing Period:

Last updated on August 23, 2019, 4:55 pm based on SEC 13F filings Last update: August 23, 2019, 4:55 pm

No.	Hedge Fund	Shares	Value (x$1000)	Activity	% Port
1.	Biotechnology Value Fund / BVF Inc Mark Lampert	6,328,994	$9,557	+81%	1.04%
2.	Highbridge Capital ManagementBOND Glenn Russell Dubin	22,625,000	$12,260		0.81%
3.	Weiss Asset ManagementBOND Andrew Weiss	3,600,000	$1,967	-57%	0.11%
4.	Whitebox AdvisorsBOND Andy Redleaf	4,500,000	$2,329		0.08%
5.	Graham Capital ManagementBOND Kenneth Tropin	3,675,000	$1,966		0.05%

Insider Trading: Purchases See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Barberich	$3.21	33,000	Director	168,000	2019-03-15	Filing
Barberich	$7.31	5,000	Director	135,000	2018-09-28	Filing
Lobacki	$7.30	3,000	Officer	10,700	2018-09-28	Filing
Paterson	$7.00	3,000	Officer	23,286	2018-09-28	Filing
Forrester	$7.00	2,000	Officer, Director	221,234	2018-09-28	Filing